FDA Approved 6 New Oncology Indications in May-July 2023

FDA Approved 6 New Oncology Indications in May-July 2023

The US FDA approved six new indications for cancer management in May-July 2023. Of these approvals, three were for hematologic malignancies, while two others address prostate cancer. Additionally, one agent received approval for endometrial cancer.  Dostarlimab for Endometrial Cancer. Dostarlimab-gxly (Jemperli, GlaxoSmithKline) received approval when administered with...
FDA Approved Six New Oncology Indications in March-April 2023

FDA Approved Six New Oncology Indications in March-April 2023
FDA Approved Six New Oncology Indications in March-April 2023

Highlights from the ASCO 2023 GU Cancers Symposium, Part 2 
FDA Approved 6 New Oncology Indications in May-July 2023

FDA Approved 6 New Oncology Indications in May-July 2023

The US FDA approved six new indications for cancer management in May-July 2023. Of these approvals, three were for hematologic malignancies, while...
FDA Approved Six New Oncology Indications in March-April 2023

FDA Approved Six New Oncology Indications in March-April 2023

The US FDA approved six new indications for cancer management in March-April 2023. Of these approvals, two were for hematologic malignancies, while...
Highlights from the ASCO 2023 GU Cancers Symposium, Part 2 

Highlights from the ASCO 2023 GU Cancers Symposium, Part 2 

The American Society of Clinical Oncology (ASCO) recently held its 2023 Genitourinary Cancers Symposium in San Francisco, California. The meeting focused on multidisciplinary approaches...
Highlights from the ASCO 2023 GU Cancers Symposium 

Highlights from the ASCO 2023 GU Cancers Symposium 

The American Society of Clinical Oncology (ASCO) recently held its 2023 Genitourinary Cancers Symposium in San Francisco, California. The meeting focused on multidisciplinary approaches...
FDA Approved 7 New Oncology Indications in January-February 2023

FDA Approved 7 New Oncology Indications in January-February 2023

In January-February 2023, the US FDA approved seven new indications for cancer management. Gynecologic cancers were well-represented: Two of these approvals were...
Highlights from the ASCO 2023 GI Cancers Symposium

Highlights from the ASCO 2023 GI Cancers Symposium

The American Society of Clinical Oncology (ASCO) recently held its 2023 Gastrointestinal Cancers Symposium in San Francisco, California, US. The meeting focused...